ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $45,576,000 | 7.97% |
| Rappaport Reiches Capital Management, LLC | 133,330 | $5,447,864 | 5.73% |
| Matrix Capital Management Company, LP | 11,800,090 | $482,152,000 | 5.27% |
| Asymmetry Capital Management, L.P. | 168,172 | $6,872,000 | 4.72% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $1,225,543,000 | 3.72% |
| Eagle Health Investments LP | 257,827 | $10,535,000 | 3.61% |
| BERYLSON CAPITAL PARTNERS, LLC | 246,200 | $10,060,000 | 2.23% |
| Aristotle Atlantic Partners, LLC | 717,650 | $29,323,000 | 1.93% |
| DDD Partners, LLC | 250,382 | $10,231,000 | 1.55% |
| Casdin Capital, LLC | 1,440,000 | $58,838,000 | 1.49% |